Torrent Pharma Inc. (TPI) is the 100% US subsidiary of Torrent Pharmaceuticals Ltd, a leading pharmaceuticals company in India with a growing presence in the global generics market. TPI was set up in 2004 and currently has 64 FDA approved generic products being commercialized in the US. Several products have leading market shares between 10-30% in their respective categories, including 14 products ranked in top 3. The company expects the US business to grow as it has rich pipeline of ANDAs and is expanding its manufacturing facilities in India. TPI is an equal opportunity employer that embraces diversity in the workplace.